Effects of carbohydrate restriction on postprandial glucose metabolism, <b>β</b>-cell function, gut hormone secretion, and satiety in patients with Type 2 diabetes

Abstract

Dietary carbohydrate restriction may improve the phenotype of Type 2 diabetes (T2D) patients. We aimed to investigate 6 wk of carbohydrate restriction on postprandial glucose metabolism, pancreatic α- and β-cell function, gut hormone secretion, and satiety in T2D patients. Methods In a crossover design, 28 T2D patients (mean HbA 1c : 60 mmol/mol) were randomized to 6 wk of carbohydrate-reduced high-protein (CRHP) diet and 6 wk of conventional diabetes (CD) diet (energy-percentage carbohydrate/protein/fat: 30/30/40 vs. 50/17/33). Twenty-four-hour continuous glucose monitoring (CGM) and mixed-meal tests were undertaken and fasting intact proinsulin (IP), 32,33 split proinsulin concentrations (SP), and postprandial insulin secretion rates (ISR), insulinogenic index (IGI), β-cell sensitivity to glucose ( B up ), glucagon, and gut hormones were measured. Gastric emptying was evaluated by postprandial paracetamol concentrations and satiety by visual analog scale ratings. A CRHP diet reduced postprandial glucose area under curve (net AUC) by 60% ( P &lt; 0.001), 24 h glucose by 13% ( P &lt; 0.001), fasting IP and SP concentrations (both absolute and relative to C-peptide, P &lt; 0.05), and postprandial ISR (24%, P = 0.015), while IGI and B up improved by 31% and 45% (both P &lt; 0.001). The CRHP diet increased postprandial glucagon net AUC by 235% ( P &lt; 0.001), subjective satiety by 18% ( P = 0.03), delayed gastric emptying by 15 min ( P &lt; 0.001), decreased gastric inhibitory polypeptide net AUC by 29% ( P &lt; 0.001), but had no significant effect on glucagon-like-peptide-1, total peptide YY, and cholecystokinin responses. A CRHP diet reduced glucose excursions and improved β-cell function, including proinsulin processing, and increased subjective satiety in patients with T2D.

Topics & Concepts